GeneDx (NASDAQ:WGS) Now Covered by Guggenheim
Investment analysts at Guggenheim began coverage on shares of GeneDx (NASDAQ:WGS – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $88.00 price target on the stock. Guggenheim’s price objective suggests a potential upside of 28.82% from the stock’s current price. WGS has […]
Investment analysts at Guggenheim began coverage on shares of GeneDx (NASDAQ:WGS – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $88.00 price target on the stock. Guggenheim’s price objective suggests a potential upside of 28.82% from the stock’s current price. WGS has […]
